Topic · page 16 of 16

Pituitary & hypothalamus

Pituitary tumors, acromegaly, prolactinoma, Cushing's disease, hypopituitarism, growth hormone deficiency in adults, arginine vasopressin deficiency, hyponatremia of endocrine cause, hypophysitis, hypothalamic disease

Briefs 601–621 of 621 placed here, newest publication first

Briefs in Pituitary & hypothalamus

Newest publication first

Clin Endocrinol (Oxf)30 Dec 2022
High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study
Case-control study
Pituitary21 Dec 2022
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review
Meta-analysis
J Clin Endocrinol Metab12 Dec 2022
Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors
Cross-sectional study
J Clin Endocrinol Metab10 Dec 2022
A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With Prolactinoma
Research article
J Clin Endocrinol Metab6 Dec 2022
Association of Preoperative Hyponatremia With Surgical Outcomes: A Systematic Review and Meta-analysis of 32 Observational Studies
Meta-analysis
Pituitary5 Dec 2022
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery
Cohort study
Pituitary3 Dec 2022
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas
Cohort study
Clin Endocrinol (Oxf)30 Nov 2022
Hypothalamic–pituitary–adrenal axis activity in patients with primary polydipsia compared to healthy controls
Secondary analysis
Pituitary29 Nov 2022
A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly
Research article
Clin Endocrinol (Oxf)28 Nov 2022
The effect of mindfulness therapy in acromegaly, a pilot study
Randomized controlled trial
Pituitary25 Nov 2022
UK practice on incidentally detected non-functioning pituitary microadenomas: analysis of two national surveys during a 12-year interval
Cross-sectional study
Pituitary23 Nov 2022
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review
Meta-analysis
J Clin Endocrinol Metab22 Nov 2022
Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors
Mechanistic study
J Clin Endocrinol Metab10 Nov 2022
ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly
Cohort study
Pituitary6 Nov 2022
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors
Cohort study
Pituitary2 Nov 2022
Delayed postoperative hyponatremia in patients with acromegaly: incidence and predictive factors
Cohort study
J Clin Endocrinol Metab24 Oct 2022
Survivin: A Potential Marker of Resistance to Somatostatin Receptor Ligands
Cross-sectional study
J Clin Endocrinol Metab10 Oct 2022
Treatment of Cushing Disease With Pituitary-Targeting Seliciclib
Cohort study
J Clin Endocrinol Metab6 Oct 2022
Obesity, Overweight, and Pituitary Stalk Interruption Syndrome in Children and Young Adults
Cohort study
Clin Endocrinol (Oxf)5 Sep 2022
The clinical and metabolic characteristics of children and adolescents with hypothalamic dysfunction: A single‐centre study from China
Cohort study
Clin Endocrinol (Oxf)4 May 2022
Sex difference in patients with controlled acromegaly—A multicentre survey
Cross-sectional study

All 621 Briefs in ExploreShowing Briefs 601–621 of 621, newest first